Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Arexvy sales exceed $500M in Q4 2024?  | Binary | 5 | 7 months ago | ||
GSK stock price up 10% by Sep 30, 2024? | Binary | 5 | 7 months ago | ||
FDA approves Pfizer or Moderna RSV vaccine for 50-59 age group by end of 2024? | Binary | 5 | 7 months ago | ||
Which company receives the next FDA approval for an RSV vaccine? | Categorical | 5 | 7 months ago | ||
Which company holds the largest market share for RSV vaccines in the 50-59 age group by Q1 2025? | Categorical | 4 | 7 months ago | ||
Impact of RSV vaccines on hospitalizations in the 50-59 age group by April 2025? | Categorical | 3 | 7 months ago |